epoprostenol sodium
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
7 FDA-registered drug labelers
Cayman Pharma s r.o.
Chirogate International Inc
EUROAPI Hungary Ltd.
GlaxoSmithKline LLC
MSN Laboratories Private Limited
Pharmacia and Upjohn Company LLC
SUN PHARMACEUTICAL INDUSTRIES, INC.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •epoprostenol
- •Flolan
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS61849-14-7
PubChem CID6364626
DTXSIDDTXSID3046617
FormulaC20H31NaO5
Mol. Weight374.4 g/mol
SMILESCCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)[O-])O2)O)O.[Na+]
Data Sources
63646262026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/epoprostenol sodium/cids/JSON
Archive: data/sources/pubchem_name/epoprostenol sodium.json
CAS 61849-14-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json